VRTX
VERTEX PHARMACEUTICALS INC / MA
NASDAQ · Healthcare · Biotechnology · US
$508.14
−1.59%Margins
Gross margin
86.0%
EBITDA margin
43.1%
EBIT margin
38.6%
Net margin
34.9%
FCF margin
30.1%
21.8%
Return on equity
16.1%
Return on assets
21.9%
Return on invested capital
0.47x
Asset turnover
$4.3B
Cash from operations
$31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026